• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期给药导致对沙丁胺醇支气管扩张作用的敏感性降低。

Subsensitivity to the bronchodilator action of albuterol produced by chronic administration.

作者信息

Nelson H S, Raine D, Doner H C, Posey W C

出版信息

Am Rev Respir Dis. 1977 Nov;116(5):871-8. doi: 10.1164/arrd.1977.116.5.871.

DOI:10.1164/arrd.1977.116.5.871
PMID:335936
Abstract

Evidence of bronchodilator subsensitivity was sought in studies using the specific beta2 adrenergic agonist, albuterol. After a period of 1 or 2 weeks off all oral sympathomimetic agents, the mean response of the patients to the first dose of albuterol was consistently greater than the response after a period during which the drug had been administered regularly. Maximal decrease in response occurred after 2 weeks' of treatment, and there was no further decrease after prolonged treatment with the same dose of albuterol for periods as long as 1 year.

摘要

在使用特定的β2肾上腺素能激动剂沙丁胺醇的研究中探寻支气管扩张剂敏感性降低的证据。在停用所有口服拟交感神经药1或2周后,患者对第一剂沙丁胺醇的平均反应始终大于在定期给药一段时间后的反应。治疗2周后反应出现最大程度下降,并且在使用相同剂量的沙丁胺醇长期治疗长达1年的时间后,反应没有进一步下降。

相似文献

1
Subsensitivity to the bronchodilator action of albuterol produced by chronic administration.长期给药导致对沙丁胺醇支气管扩张作用的敏感性降低。
Am Rev Respir Dis. 1977 Nov;116(5):871-8. doi: 10.1164/arrd.1977.116.5.871.
2
Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.福莫特罗常规治疗稳定期哮喘患者后β2肾上腺素能受体调节及支气管扩张剂敏感性
J Allergy Clin Immunol. 1998 Mar;101(3):337-41. doi: 10.1016/S0091-6749(98)70245-3.
3
Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.规律使用福莫特罗后对沙丁胺醇的支气管扩张反应及急性给予皮质类固醇的影响。
Chest. 2000 Jan;117(1):156-62. doi: 10.1378/chest.117.1.156.
4
Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates.Clickhaler(一种新型干粉吸入器)即使在低流速情况下,也能提供与压力定量吸入器相似的支气管扩张效果。
Chest. 1999 Apr;115(4):952-6. doi: 10.1378/chest.115.4.952.
5
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.哮喘患者定期使用沙丁胺醇治疗:基因分型分层、随机、安慰剂对照交叉试验。
Lancet. 2004;364(9444):1505-12. doi: 10.1016/S0140-6736(04)17273-5.
6
Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.哮喘患者每日两次使用沙美特罗后对沙丁胺醇的支气管扩张剂敏感性降低。
Lancet. 1995 Jul 22;346(8969):201-6. doi: 10.1016/s0140-6736(95)91265-7.
7
Acute effect of an inhaled glucocorticosteroid on albuterol-induced bronchodilation in patients with moderately severe asthma.吸入性糖皮质激素对中度重度哮喘患者沙丁胺醇诱导的支气管扩张的急性作用。
Chest. 2015 Apr;147(4):1037-1042. doi: 10.1378/chest.14-1742.
8
Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols: response to albuterol, isoproterenol, and placebo aerosols.与异丙肾上腺素气雾剂和安慰剂气雾剂相比,沙丁胺醇气雾剂的剂量-反应效应:对沙丁胺醇、异丙肾上腺素和安慰剂气雾剂的反应
J Allergy Clin Immunol. 1977 Apr;59(4):280-6. doi: 10.1016/0091-6749(77)90048-3.
9
Double-blind, crossover comparison of carbuterol and salbutamol.卡布特罗与沙丁胺醇的双盲交叉对照研究
Ann Allergy. 1979 Aug;43(2):123-5.
10
Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.异丙托溴铵/沙丁胺醇与沙丁胺醇治疗中重度哮喘患者的疗效和安全性比较:一项随机对照试验
BMC Pulm Med. 2016 Apr 30;16(1):65. doi: 10.1186/s12890-016-0223-3.

引用本文的文献

1
Asthma Ambulatory Care Quality in Foreign-Born Latino Children in the United States.美国出生的拉丁裔儿童哮喘门诊护理质量。
Acad Pediatr. 2022 May-Jun;22(4):647-656. doi: 10.1016/j.acap.2021.10.003. Epub 2021 Oct 22.
2
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.福莫特罗和吸入皮质类固醇与沙美特罗和吸入皮质类固醇常规治疗慢性哮喘:严重不良事件。
Cochrane Database Syst Rev. 2021 Apr 14;4(4):CD007694. doi: 10.1002/14651858.CD007694.pub3.
3
Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.
用于哮喘治疗的吸入性类固醇联合或不联合常规沙美特罗:严重不良事件
Cochrane Database Syst Rev. 2018 Dec 3;12(12):CD006922. doi: 10.1002/14651858.CD006922.pub4.
4
Regular treatment with formoterol for chronic asthma: serious adverse events.福莫特罗用于慢性哮喘的常规治疗:严重不良事件
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD006923. doi: 10.1002/14651858.CD006923.pub3.
5
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.福莫特罗常规治疗与沙美特罗常规治疗慢性哮喘的严重不良事件
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD007695. doi: 10.1002/14651858.CD007695.pub3.
6
Regular treatment with salmeterol for chronic asthma: serious adverse events.沙美特罗用于慢性哮喘的常规治疗:严重不良事件
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD006363. doi: 10.1002/14651858.CD006363.pub2.
7
Recovery from bronchoconstriction and bronchodilator tolerance.支气管收缩的恢复与支气管扩张剂耐受性
Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):181-96. doi: 10.1385/CRIAI:31:2:181.
8
Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.吸入性短效β2受体激动剂在哮喘治疗中的应用:规律治疗与按需治疗
Cochrane Database Syst Rev. 2000;2003(4):CD001285. doi: 10.1002/14651858.CD001285.
9
Clinical management of asthma in the 1990s. Current therapy and new directions.20世纪90年代哮喘的临床管理。当前的治疗方法与新方向。
Drugs. 1996;52 Suppl 6:1-11. doi: 10.2165/00003495-199600526-00003.
10
Pharmacodynamic modelling of the drug-induced downregulation of a beta 2-adrenoceptor mediated response and lack of restoration of receptor function after a single high dose of prednisone.单次高剂量泼尼松后药物诱导的β2-肾上腺素能受体介导反应下调及受体功能缺乏恢复的药效学模型
Eur J Clin Pharmacol. 1995;49(1-2):37-44. doi: 10.1007/BF00192356.